Supply Chain Analytics: Pharma’s Next Big Bet
Examining a new three-part formula to enable the supply chain function to manage market pressures while delivering on the bottom line.
Beyond the Blame Game: How Pharma is Learning to Collaborate
In a follow-up to our November CEO profile, Novo Nordisk’s Jesper Høiland writes how pharma companies and insurers are learning to collaborate.
Marketing: Beware the Hidden Forces of Behavioral Economics
Brand success can hinge on discovering the deeper motivations of customers and addressing the cognitive biases that result.
The Industry's Score on Five Key Performance Measures
I offered up a prediction: that the future of the biopharmaceutical business depended on how managers fared on five key measures of performance.
What’s Ahead for 2015? Pharm Exec's Industry Outlook
Pharm Exec’s annual report highlights the key scientific, commercial, and reputational trends shaping the industry in the year ahead.
Got Ideas? Go North!
The Canadian R&D industry, which boasts a rich history of drug innovation, celebrates a series of anniversaries.
Sanofi’s Big Bet on Integrated Patient Care
Pharm Exec profiles Sanofi EVP Pascale Witz, tagged with the assignment to move a lumbering biopharma giant closer to the embrace of the patient perspective in healthcare.
Country Report: Malaysia
With spending on healthcare increasing in Malaysia, access to innovative drugs remains a challenge as the country juggles its dual public-private health system.
